Hydrogen Therapy Improves Brain Function in Glioma Cancer Patients
- Authors
- Yan Li, Li Zhang, Shengjun Wang, Yumin Feng, Zhiyin Pang, Wenjian Zhen, Jinmin Hao
- Journal
- Alternative Therapies in Health and Medicine
- Year
- 2024
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Brain Glioma
- Body System
- Nervous System
TL;DR
Inhaling hydrogen gas improves nerve function and reduces harmful oxidative stress in brain cancer patients, potentially making it a helpful additional treatment.
Key Finding
Patients with brain glioma who received hydrogen inhalation therapy combined with standard treatment showed significantly better overall clinical improvement (90% vs 72%) and better recovery of nerve function compared to those receiving standard treatment alone.
Summary
This study tested whether inhaling hydrogen gas could help brain tumor (glioma) patients recover better when combined with standard treatment. Researchers divided 100 patients into two groups: one receiving standard treatment alone and one receiving standard treatment plus hydrogen inhalation for 2 weeks. The hydrogen group showed better overall improvement (90% vs 72%), better nerve function recovery, lower markers of cellular damage (oxidative stress), and higher levels of a protein (E-cadherin) associated with cell stability.
Practical Takeaway
This small, short-term study suggests hydrogen inhalation may support standard glioma treatment, but it has important limitations: it only lasted 2 weeks, involved a relatively small number of patients, and lacked details about long-term outcomes. Much more research is needed before hydrogen therapy could be considered a proven treatment option for brain tumors. Anyone with glioma should discuss any complementary therapies with their oncologist before trying them.
Abstract (excerpt)
Objective: This study aims to evaluate the effects of hydrogen therapy on nerve function and tumor progression markers in glioma patients, focusing on the modulation of oxidative stress and cadherin expression to establish its potential as a complementary treatment. Methods: 100 glioma patients…